Table 3.

Distress and symptom burden.

	All patients			Group A			Group B
	N	M	SD	N	M	SD	N	M	SD	p 1
PHQ-9	31	9.23	6.08	17	7.88	5.36	14	10.86	6.69	0.297
GAD-7	31	6.00	4.98	17	5.47	5.17	14	6.64	4.58	0.493
PHQ-15	30	5.93	4.84	16	5.31	5.76	14	6.64	3.61	0.131
QSC-R10	30	16.30	11.23	17	14.88	10.56	13	18.15	12.23	0.483
SF-8 PCS	31	44.30	10.13	17	46.79	10.14	14	41.27	9.60	0.142
SF-8 MCS	31	38.67	11.82	17	38.91	12.43	14	38.38	11.50	0.937
PCL-C	31	35.10	13.29	17	32.71	14.99	14	38.00	10.71	0.118
FOP-Q-SF	30	19.33	10.67	16	19.00	11.10	14	19.71	10.56	0.835

Group A, benign tumours; Group B, malignant tumours; M, mean; SD, standard deviation; p, type-I-error-probability; PHQ-9, Patient Health Questionnaire; GAD-7, Generalised Anxiety Disorder 7; PHQ-15, 15-question somatic symptom scale from the Patient Health Questionnaire; QSC-R10, Questionnaire on Distress in Cancer Patients– short form; SF-8, Short-Form Health Survey; PCS, physical component summary; MCS, mental component summary; PCL-C, Posttraumatic Stress Disorder Checklist-Civilian Version; and FOP-Q-SF, Fear of Progression Questionnaire Short Form.

¹Mean differences were tested with Mann-Whitney U-test.